Drug Dependence (ECDD). Following the critical review of CBD at the ECDD’s 40th meeting, it was recommended that “pure CBD should not be scheduled in the International Drug Control Conventions.” Further clarifications were recently added outlining that CBD preparations containing less than 0.2% THC should be removed from the drug convention